Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issues
Author:
Open Access
- 1 July 2009
- journal article
- review article
- Published by Elsevier in Annals of Hepatology
- Vol. 8 (3) , 184-195
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Kava hepatotoxicity: Regulatory data selection and causality assessmentDigestive and Liver Disease, 2009
- Drug-induced liver injury following positive drug rechallengeRegulatory Toxicology and Pharmacology, 2009
- Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava–herbs mixturesJournal of Ethnopharmacology, 2009
- Drug-Induced Hepatotoxicity or Drug-Induced Liver InjuryClinics in Liver Disease, 2009
- Causality assessment in hepatotoxicity by drugs and dietary supplementsBritish Journal of Clinical Pharmacology, 2008
- Drug-Induced HepatotoxicityJournal of Clinical Gastroenterology, 2005
- Drug-induced acute liver failureEuropean Journal of Gastroenterology & Hepatology, 2005
- Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials?Toxicologic Pathology, 2005
- Workshop Overview: Hepatotoxicity Assessment for Botanical Dietary SupplementsToxicological Sciences, 2004
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003